Researcher
Marc Jacquemin
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From23 Nov 2000 → Today
Projects
1 - 5 of 5
- Rapid and easy-to-perform FO-SPR-based assays for VWF antigen and functionality and insights into the vaccine-induced adaptive immune response against SARS-CoV-2From1 Aug 2019 → 25 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Addition of ImageStream facilities to the FACS CoreFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Cellular Interactions and Heterogeneity in Ischemic Cardiovascular DiseaseFrom1 Nov 2010 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
- Development of an innovative platform for generation of tailor-made fully human therapeutic monoclonal antibodies against human targetsFrom1 Jan 2010 → 31 Dec 2013Funding: SBO (Strategic basic research)
- PharmAbs: K.U.Leuven Antibody Center.From1 Sep 2009 → TodayFunding: IOF - Industrial Research Fund, IOF - mandates
Publications
11 - 20 of 71
- Optimization of the detection of inhibitory autoantibodies against the VWF-cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay(2021)
Authors: Marc Jacquemin, Kathelijne Peerlinck, Daan Dierickx
Pages: 290 - 297 - Acquired von Willebrand Syndrome in left Impella supported cardiogenic shock patients(2020)
Authors: Christophe Vandenbriele, Peter Verhamme, Marc Jacquemin
Pages: 1538 - 1538 - Anticoagulant therapy in COVID-19 critically ill: Should we go for more?(2020)
Authors: Christophe Vandenbriele, Lucas Van Aelst, Dieter Dauwe, Marion Delcroix, Jan Gunst, Marc Jacquemin, Kathelijne Peerlinck, Thomas Vanassche, Joost Wauters, Alexander Wilmer, et al.
Pages: 156 - 158 - Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis(2020)
Authors: Marijke Peetermans, Severien Meyers, Laurens Liesenborghs, Karen Vanhoorelbeke, Simon De Meyer, Christophe Vandenbriele, Marc Hoylaerts, Kim Martinod, Marc Jacquemin, Thomas Vanassche, et al.
Pages: 722 - 731 - The concentration of GPIbα magnetic particles is a critical parameter occasionally responsible for poor reproducibility of the VWF:GPIbR chemiluminescent immunoassay(2019)
Authors: Bas Calcoen, Kathelijne Peerlinck, Marc Jacquemin
Pages: e79 - e80 - Measurement of factor VIII activity of efraloctocog alfa with commercially available one-stage clotting and chromogenic assays: Results from the Belgian national External Quality Assessment Scheme(2019)
Authors: Marjan Van Blerk, Bernard Chatelain, Katrien Devreese, Marc Jacquemin, Kristin Jochmans, Francois Mullier, Mohamed R Soumali, Sylvia Broeders
Pages: E20 - E22 - Pure ultra-fine carbon particles do not exert pro-coagulation and inflammatory effects on microvascular endothelial cells(2019)
Authors: Marc Hoylaerts, Marc Jacquemin
Pages: 991 - 999 - Does haemophilia slow down the development of liver fibrosis?(2019)
Authors: Marie-Astrid van Dievoet, Isabelle Leclercq, Cedric Hermans, Catherine Lambert, Yves Horsmans, Marc Jacquemin, Stephane Eeckhoudt
Pages: E32 - E35 - Accurate measurement of extended half-life and unmodified factor VIII low levels with one-stage FVIII assays is dependent on the matrix of calibration curves(2019)
Authors: Kathelijne Peerlinck, Marc Jacquemin
Pages: E19 - E26 - A rare presentation of homozygous factor X deficiency in a pregnant patient: A case report and review of the literature(2019)
Authors: Marc Jacquemin, Kristel Van Calsteren, Kathelijne Peerlinck
Pages: E57 - E59